when fda approve compass pathways comp360 psilocybin

    Before October 2027

    when fda approve compass pathways comp360 psilocybin. Best Yes near 90¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 90¢ · Best No: 18¢ · 1 platform

    • Kalshi: Yes 90¢ / No 18¢
    TRADING OPEN

    Before October 2027

    Volume

    $2.3K

    $0 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Jun 30, 2027

    ~288 days left

    Category

    Culture

    90¢CHANCE OF YES83%17%
    Yes
    90¢
    Kalshi
    No
    18¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    kalshi
    Kalshi
    Best Yes
    Best No
    Yes
    90¢
    No
    18¢
    Vol
    $2.3K
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 90¢: exit costs ~0.63¢/contract
    Full calculator

    Market Details

    ResolutionResolves Jun 30, 2027
    Time Left288 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In